Bone density and hormonal balance rarely come up in a routine neurology follow-up, and that can be a real gap — because some anti-seizure medications can affect one or both over time. The risks and mechanisms differ by medication: certain older enzyme-inducing drugs have the clearest shared pathway involving vitamin D metabolism and sex hormones, while other medications can have different effects. Understanding those distinctions makes both conversations easier to have, and easier to know when to raise them yourself. This is one of several conversations worth bringing to a neurology appointment — see the fuller list in Questions to Ask Your Neurologist.
In This Article
One Mechanism, Two Affected Systems
Several older, widely-used anti-seizure medications — phenobarbital, phenytoin, and carbamazepine chief among them — share a property called hepatic enzyme induction: they ramp up the activity of liver enzymes in the cytochrome P450 system. That system’s job is normally to metabolize a wide range of substances the body needs to process, including vitamin D and sex hormones. When those enzymes get induced into overdrive by long-term medication use, they metabolize these substances faster than usual, converting active vitamin D into inactive forms and increasing production of sex hormone-binding globulin (SHBG), a protein that binds up circulating testosterone and estradiol. That single mechanism is the common thread connecting reduced bone density and altered hormone levels — two seemingly unrelated effects with the same pharmacological root. This connects to the broader picture covered in Impact of Epilepsy on Body Systems; this piece goes considerably deeper into these two specific systems.
What This Does to Bone
The mechanism plays out specifically like this: enzyme induction accelerates the conversion of 25-hydroxyvitamin D into inactive metabolites, which reduces intestinal calcium absorption, which in turn triggers secondary hyperparathyroidism — the parathyroid glands releasing more hormone to compensate for lower blood calcium, which pulls calcium out of bone to maintain blood levels. Multiple peer-reviewed reviews have found this pattern associated with meaningfully reduced bone mineral density and elevated fracture risk, with one review estimating anticonvulsant use increases fracture odds by roughly 1.2 to 2.4 times compared to the general population. Valproate, which doesn’t induce liver enzymes the same way, appears to affect bone through a separate, less well-understood pathway — meaning this isn’t purely an enzyme-induction story, though the enzyme-inducing drugs carry the most consistent evidence. Bone loss has been documented starting within the first one to five years of treatment in some studies, not only after decades — worth knowing, since it means this isn’t only a concern for people who’ve been on medication a very long time.
Hormonal Effects in Men
In men, the SHBG elevation from enzyme-inducing medications binds up a larger share of circulating testosterone and estradiol, reducing the biologically active, unbound portion even when total testosterone on a standard lab panel looks unremarkable — which is part of why this effect gets missed if the wrong test is ordered. One study comparing men with epilepsy on enzyme-inducing medications, men on lamotrigine (which doesn’t induce enzymes the same way), and men on no medication found significantly lower bioactive testosterone and lower sexual function scores specifically in the enzyme-inducing group — nearly a third of men in that group had abnormally low scores, compared to roughly one in twenty in the lamotrigine group. This effect has also been shown to reverse after discontinuing an enzyme-inducing medication, which is a genuinely useful, hopeful data point for anyone considering a medication change with their neurologist.
Hormonal Effects in Women — and the Contraceptive Interaction Gap
Women face the same SHBG-mediated reduction in bioactive hormone levels, which can show up as menstrual irregularity, alongside a separate and genuinely urgent issue: enzyme-inducing anti-seizure medications measurably reduce the effectiveness of hormonal contraceptives, by accelerating the metabolism of both estrogen and progestin components. This is not a minor footnote — one analysis estimated this specific drug interaction contributes to more than 500 unintended pregnancies annually in the United States, with real associated healthcare costs. The reverse interaction matters too: some hormonal contraceptives can lower blood levels of lamotrigine specifically, potentially increasing seizure risk, which is exactly why any change to either medication or contraception needs to happen in coordination with a neurologist rather than independently with a gynecologist alone.
Not every contraceptive method is affected equally, and this distinction matters practically. Standard combined oral contraceptives and subdermal implants lose meaningful efficacy when combined with enzyme-inducing anti-seizure medications. Levonorgestrel-releasing and copper IUDs, along with the injectable DMPA, are not meaningfully affected by enzyme induction and remain reliable options for women on these medications. Valproate carries its own distinct hormonal profile unrelated to enzyme induction — it’s been associated with increased testosterone, menstrual disturbances, and elevated risk of polycystic ovary syndrome, a genuinely different mechanism from the enzyme-inducing drugs discussed above.
Thyroid Function and Other Effects
Enzyme-inducing medications can also reduce circulating T3, T4, and free T4 on standard thyroid panels — worth knowing so an unexpected result doesn’t cause alarm out of context. Encouragingly, patients typically remain clinically euthyroid despite these lab changes, meaning the numbers shift without producing the symptoms of an underactive thyroid. This is a real, documented effect, but generally a lower-stakes one than the bone and reproductive-hormone effects discussed above.
What to Test, and How Often
Whether a DEXA scan is appropriate depends on the specific medication exposure and a person’s age, fracture history, duration of treatment, and other bone-health risk factors. When bone effects are a concern, a clinician may also consider laboratory testing such as vitamin D or other markers of calcium and bone metabolism based on the individual situation. Hormonal testing is similarly best guided by the medication, symptoms, reproductive considerations, and other risk factors; when androgen effects are suspected, for example, total testosterone, free testosterone, and SHBG may provide more context than total testosterone alone. The practical point is not that everyone taking an anti-seizure medication needs the same DEXA or laboratory panel, but that medication-specific risks are worth reviewing with a neurologist or primary care provider.
Shop What I Actually Use
For monitoring and supporting bone and hormonal health more broadly, my full Amazon storefront reflects what I actually use and recommend day to day.
Affiliate disclosure: As an Amazon Associate I earn from qualifying purchases. See the Affiliate Disclosure for details.
Hydration & Electrolyte Support
Hydration and electrolyte balance matter in the broader picture of neurological health, medication effects, and day-to-day recovery. Buoy is what I actually use for that support.
A Supplement Source I Trust
For the vitamin D and K2 pairing worth discussing with a provider in this context, Vimergy is one of the few sources I trust for clean, well-formulated options.
Having This Conversation With Your Neurologist
These topics rarely come up unprompted in a standard follow-up, not because they’re unimportant, but because a 15-to-20-minute appointment is usually focused on seizure control itself. Bringing a specific, direct question — “given my current medication, should we be monitoring bone density or hormone levels?” — tends to open the conversation far more effectively than a general mention of fatigue or low mood, since those symptoms alone don’t point a busy appointment toward this specific mechanism.
Want the complete Epilepsy Support Guide?
Seizure types and triggers, medication management, SUDEP awareness, seizure first aid, and how to find quality medical care, all in one free guide.
FAQ
Does this affect everyone on anti-seizure medication?
No — these effects are most consistently documented with the older enzyme-inducing medications specifically (phenobarbital, phenytoin, carbamazepine). Newer, non-enzyme-inducing medications carry meaningfully less evidence for these particular effects, though valproate has its own distinct hormonal profile.
Should I stop my medication because of this?
No — this is not a reason to adjust or discontinue a seizure medication independently. It’s a reason to have an informed conversation with a neurologist about monitoring and, if appropriate, whether an alternative medication makes sense for your specific situation.
If I’m on an affected medication, does that mean my birth control definitely won’t work?
Not necessarily — it means standard oral contraceptives and implants carry meaningfully reduced reliability in this specific combination, which is worth a direct conversation between a neurologist and prescribing provider about contraceptive options less affected by the interaction.
Conclusion
Bone density and hormonal health are not side conversations to long-term epilepsy management. Some anti-seizure medications, particularly certain older enzyme-inducing drugs, have documented effects on bone or hormone metabolism, while other medications have different or less clearly established risk profiles. None of this is a reason for alarm. It’s a reason to ask specific questions, discuss individualized monitoring, and treat medication-specific long-term effects as a normal part of epilepsy care rather than something that only comes up after a problem has developed. For the broader treatment and management context, see Understanding Epilepsy.
Sources & Further Reading
- Antiepileptics and Bone Health — PubMed
- Antiseizure Medications and Oral Contraceptives: Impact of Enzyme Inducers on Pregnancy Outcomes and Costs
- Neuroendocrine Considerations in the Treatment of Men and Women With Epilepsy — PMC
- ACOG — Gynecologic Management of Adolescents and Young Women With Seizure Disorders
Disclaimer
Content on Real David Julian is provided for educational and informational purposes and may include research-based discussion, personal experience, and opinion. It is not medical advice and is not a substitute for individualized care from a qualified healthcare professional. Always discuss your specific health needs, diagnoses, medications, supplements, treatments, or major health decisions with an appropriate healthcare professional. See the full Disclaimer for additional information.